not really, it's a complementary technology at this point, the TKMR tech is already proven. It will take years before we know what this new tech will do, and for which patients or indications it will have benefit. There is a lot of technology in development that may be competing with the tekmira tech. Even tekmira's new tech, but that's not interesting at this point. The first that will come to market with a drug will be interesting if it works good enough.
>>If I had to guess, I'd say the program is dead
At least on hold. Given the results and that it is a platform, not just for ebola, we may see some new contract in the future.
completion takes time, given the litigation, it doesn't really matter if it takes a few more weeks or even another 6 months.